Patent details
300481 Product Name: Naproxen en esomeprazol.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300481
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1411900
- Status:
- Expired Art. 14 (a) of the EC Regulations
- Application number:
- 300481
- Procedural language:
- Dutch
- First Applicant Residence Country:
Marketing Authorization
1
- Marketing Authorization Number:
- RVG 106235
- Marketing Authorization Type:
- National/EU
- Marketing Authorization Date:
- 18/11/2010
- Marketing Authorization Country:
- Netherlands (NL)
2
- Marketing Authorization Number:
- PL 17901/0263-001
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 05/11/2010
- Marketing Authorization Country:
- United Kingdom (GB)
Dates
- Filing date:
- 11/05/2011
- First Marketing Authorization date:
- 05/11/2010
- Grant date:
- 14/06/2011
- Activation date:
- 31/05/2022
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 11/05/2011
- SPC/SPC Extension Expiration Date:
- 04/11/2025
- Lapsed By Expiration Date:
- 05/11/2025
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 17/05/2024
- Name:
- Nuvo Pharmaceuticals (Ireland) Designated Activity Company
- Address:
- 88 Harcourt Street, D02 DK18, Dublin 2, Ireland (IE)
Historical Applicant/holder
- From:
- 19/04/2024
- To:
- 17/05/2024
- Name:
- Nuvo Pharmaceuticals (Ireland) Designated Activity Company
- Address:
- 88 Harcourt Street, DO2 DK18, Dublin 2, Ireland (IE)
- From:
- 28/02/2020
- To:
- 28/02/2020
- Name:
- Pozen, Inc.
- Address:
- 400 Alexander Park Drive, 08540, Princeton NJ , United States of America (US)
- From:
- 28/02/2020
- To:
- 19/04/2024
- Name:
- Nuvo Pharmaceuticals (Ireland) Designated Activity Company
- Address:
- 2 Hume Street, DO2 FT82, Dublin 2, Ireland (IE)
Agent
- Name:
- dr. ir. G.J.C. Verdijck c.s.
- From:
- 11/05/2011
- Address:
- Octrooibureau Arnold & Siedsma p/a Postbus 18558, 2502 EN, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 45/25
- Publication date:
- 05/11/2025
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 22/22
- Publication date:
- 01/06/2022
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- CO
- Journal edition number:
- 10/20
- Publication date:
- 08/05/2020
- Description:
- Changes in the Netherlands Patent Register
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 2011/25
- Publication date:
- 22/06/2011
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 2011/20
- Publication date:
- 18/05/2011
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC202400937A
- Date Registered:
- 17/05/2024
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. ir. G.J.C. Verdijck c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC202400775A
- Date Registered:
- 19/04/2024
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. ir. G.J.C. Verdijck c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC202000462A
- Date Registered:
- 28/02/2020
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. ir. G.J.C. Verdijck c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202000462B
- Date Registered:
- 28/02/2020
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. ir. G.J.C. Verdijck c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Nuvo Pharmaceuticals (Ireland) Designated Activity Company
- Address:
- 2 Hume Street, DO2 FT82, Dublin 2, Ireland (IE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 29/04/2025
- Last Annual Fee Paid Number:
- 24
- Last Annual Fee Paid Amount:
- 2200 Euro
- Payer:
- Computer Packages Inc. (CPI)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 14/06/2011 | Outgoing Correspondence | Outgoing Letter | 1 | /1/8/4/0/0/0400300481/docs/300481_3_outgoingcorrespondence20110614.pdf | ||
| 14/06/2011 | SPC Documents | Certificate SPC | 1 | /1/8/4/0/0/0400300481/docs/300481_4_supplprotectioncertificate20200909120931272.pdf | ||
| 12/05/2011 | Outgoing Correspondence | Outgoing Letter | 1 | /1/8/4/0/0/0400300481/docs/300481_7_outgoingcorrespondence20110512.pdf | ||
| 11/05/2011 | SPC Documents | Summary of the characteristics of the product | 30 | /1/8/4/0/0/0400300481/docs/300481_0_supplprotectioncertificate20200909120006453.pdf | ||
| 11/05/2011 | SPC Documents | Summary of the characteristics of the product | 24 | /1/8/4/0/0/0400300481/docs/300481_1_supplprotectioncertificate20200909120302583.pdf | ||
| 11/05/2011 | Application Form | First filed application form | 4 | /1/8/4/0/0/0400300481/docs/300481_2_applicationform20110511.pdf | ||
| 11/05/2011 | SPC Documents | Marketing Authorization SPC | 3 | /1/8/4/0/0/0400300481/docs/300481_5_supplprotectioncertificate20200909120711672.pdf | ||
| 11/05/2011 | SPC Documents | Marketing Authorization SPC | 1 | /1/8/4/0/0/0400300481/docs/300481_6_supplprotectioncertificate20200909120515990.pdf |